BioSpace News Archive

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) and SOLTI-Innovative Cancer Research today announced the acceptance of an abstract for a poster presentation at the upcoming European Society for Medical Oncology Breast Cancer Meeting.

Compugen Ltd. announced today that the Company will release its first quarter 2022 financial results on Monday, May 16, 2022 before the U.S. financial markets open.

InMode Ltd. announced its consolidated financial results for the first quarter ended March 31, 2022.

Alkermes plc (Nasdaq: ALKS) today announced plans to present research related to its psychiatry portfolio at four scientific conferences during Mental Health Awareness Month in May.

Blue Spark Technologies Inc. announced today the appointment of John DeFord, Ph.D. to its board of directors.

Can-Fite BioPharma Ltd today announced the Company’s CEO Dr. Pnina Fishman has been invited as an expert speaker to deliver a presentation titled “Targeting the A3 Adenosine Receptor for the Treatment of Advanced Liver Cancer” at the Adenosine Pathway Targeted Cancer Immunotherapy Summit in Boston on May 12, 2022.

Precision BioSciences, Inc today announced that it will publish financial results for the first quarter 2022 and provide a business update on May 9, 2022.

Santen’s Verkazia ® (Cyclosporine Ophthalmic Emulsion) 0.1% Now Available for the Treatment of Vernal Keratoconjunctivitis in Children and Adults in the United States.

Nevakar Injectables Inc., a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings.

Intellia Therapeutics, Inc. today announced the presentation of new preclinical data from its differentiated allogeneic cell engineering platform at Keystone Symposia’s Precision Genome Engineering Conference, taking place April 27 – May 1, 2022, in Keystone, Colorado.